Gender

Gender is considered a main issue in Horizon 2020, the largest ever EU Research and Innovation programme, with €80 billion worth of funding available over seven years. The European Commission has identified seven priority areas of societal challenges, with the goal targeting investment in research in these fields. They are:

As reported in the ASSET Strategic plan, the three Summer Schools on Science in Society related issues in Pandemics (2015, 2016, 2017) pose the main challenge of the collaborative project overall that is dealing with the intersectoral approach required by the management of Public Health Emergencies of International Concern (PHEIC), like epidemics and pandemics.

It is often said that sex and gender differences are perceived as overlooked in research design and in clinical trials, even those on vaccines. In 2010, the World Health Organisation (WHO) published the document Sex, gender and influenza, which states that many reports of influenza vaccination rates as well as the safety, efficacy and effectiveness of vaccines around the world do not disaggregate data by sex.

Wednesday, April 26, 2017 (All day)

Members of the ASSET projects will present the results of the citizen consultation that took place in eight countries on September 2016 at the European Parliament. Such an event is part of the science-in-society approach performed by the project within the framework of Research and Innovation related to pandemic preparedness. ASSET citizen consultation is an innovative method of engaging citizens on complex issues, providing them with information before asking questions.

Tuesday, May 30, 2017 - 09:00

The third edition of the ASSET Summer School will be held at the National Centre for Diseases Prevention and Health Promotion (CNaPPS) of the Istituto Superiore di Sanità (ISS) in Rome from May 30 to June 1, 2017. Pandemics (or more in general public health emergencies of international concern, PHEIC) as well as other major infectious disease outbreaks management do necessarily require a multidisciplinary approach. The ASSET Summer School focuses on

The second edition of the ASSET best practice award for general practitioners has come to an end, with the assignment of the four grants to health professionals or groups of health professionals working in the primary health sector.

Gender issue in clinical trials in Europe

Internationally, the issue of including women in clinical trials of medicines has been addressed in various guidelines issued by the International Conference on Harmonization (ICH), which promotes regulatory standards for clinical trials. While ICH has specific guidelines on the conduct of clinical trials in paediatric and geriatric populations, there are no consolidated guidelines for the investigation of medicinal product in women.

An underlying principle of drug development is that “patients entering clinical trials should be reasonably representative of the population that will be later treated by the drug” as subpopulations may respond differently to a given drug treatment. 
While ICH has developed specific guidelines that deal with the participation of geriatric and pediatric subjects in the drug development process, this has not been the case for the clinical investigation of medicinal products in women. Direct and indirect references to gender do, however, appear throughout a number of ICH guidelines.

Topic: 

Taking Action to Improve the Evidence Base for Policies by Changing Gender Imbalances in the Content and Process of Health Research. 

What are the mechanisms behind gender imbalances in the contents and processes of health research?
Gender discrimination and bias not only affects differentials in health needs, health seeking behaviour, treatment, and health outcomes but also influences the content and the process of health research.

 

Topic: 

Pages

Subscribe to Gender

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Effective communication in outbreak management: development of an evidence-based tool for Europe
Developing the framework for an epidemic forecast infrastructure
European monitoring of excess mortality for public health action
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Medical ecosystem – personalized event-based surveillance
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence